Basics Amgen Inc. Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics. IPO Date: January 2, 1990 Sector: Healthcare Industry: Biotech Market Cap: $148.96B Activated in VL: True Average Daily Range Avg Daily Range: $1.36 | 0.99% Avg Daily Range (30 D): $3.97 | 1.35% Avg Daily Range (90 D): $3.46 | 1.19% Institutional Daily Volume Avg Daily Volume: 4.86M Avg Daily Volume (30 D): 2.3M Avg Daily Volume (90 D): 2.38M Trade Size Avg Trade Size (Sh.): 135 Avg Trade Size (Sh.) (30 D): 40 Avg Trade Size (Sh.) (90 D): 43 Institutional Trades Total Inst.Trades: 112,634 Avg Inst. Trade: $6.13M Avg Inst. Trade (30 D): $39.69M Avg Inst. Trade (90 D): $33.89M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 20 Market Closing Trades Avg Closing Trade: $63.74M Avg Closing Trade (30 D): $201.77M Avg Closing Trade (90 D): $181.95M Avg Closing Volume: 385.93K         News Apr 22, 2025 @ 9:37 PM Why Vertex Pharmaceuticals Was Such a Healthy Stoc... Source: Eric Volkman Apr 22, 2025 @ 1:53 PM 3 Relatively Safe Healthcare Growth Stocks You Can... Source: The Motley Fool Apr 14, 2025 @ 2:00 PM [Corrected] Sandoz files antitrust litigation agai... Source: N/A Apr 10, 2025 @ 9:59 AM Biopharmaceuticals Global Overview Report 2025: Gl... Source: Researchandmarkets.Com Apr 8, 2025 @ 8:48 AM Minimal Residual Disease Testing Market Forecast R... Source: Researchandmarkets.Com Financials   TTM Q3 2024 Q2 2024 Basic EPS $7.89 $5.27 $1.39 Diluted EPS $7.82 $5.22 $1.38 Revenue $ 32.53B $ 8.5B $ 8.39B Gross Profit $ 19.68B $ 5.19B $ 5.15B Net Income / Loss $ 4.23B $ 2.83B $ 746M Operating Income / Loss $ 6.22B $ 2.05B $ 1.91B Cost of Revenue $ 12.86B $ 3.31B $ 3.24B Net Cash Flow $ -25730M $ -290M $ -407M PE Ratio 35.97